124 related articles for article (PubMed ID: 29681174)
1. [The patients' cost of the montelukast therapy due to the generic substitution].
Répásy B; Endrei D; Zemplényi A; Ágoston I; Boncz I
Orv Hetil; 2018 Apr; 159(17):682-687. PubMed ID: 29681174
[TBL] [Abstract][Full Text] [Related]
2. [The effect of generic price competition on drug consumption and health insurance pharmaceutical expenditures in Hungary].
Répásy B; Endrei D; Zemplényi A; Agoston I; Hornyák L; Nagy Z; Csákvári T; Vajda R; Boncz Imre
Acta Pharm Hung; 2015; 85(3):83-8. PubMed ID: 26642646
[TBL] [Abstract][Full Text] [Related]
3. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
McManus P; Birkett DJ; Dudley J; Stevens A
Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
[TBL] [Abstract][Full Text] [Related]
5. The long-term effect of generic price competition on the Hungarian statin market.
Répásy B; Gazsó T; Elmer D; Pónusz-Kovács D; Kajos FL; Csákvári T; Kovács B; Boncz I
BMC Health Serv Res; 2023 May; 23(1):447. PubMed ID: 37147682
[TBL] [Abstract][Full Text] [Related]
6. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
7. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
[TBL] [Abstract][Full Text] [Related]
8. Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
Price DB; Ben-Joseph RH; Zhang Q
Respir Med; 2001 Jan; 95(1):83-9. PubMed ID: 11207023
[TBL] [Abstract][Full Text] [Related]
9. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
Kong Y
Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
[TBL] [Abstract][Full Text] [Related]
10. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
11. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
12. Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy.
Spinks J; Chen G; Donovan L
Aust Health Rev; 2013 Nov; 37(5):675-81. PubMed ID: 24160374
[TBL] [Abstract][Full Text] [Related]
13. Montelukast. No current use for asthma.
Can Fam Physician; 2000 Jan; 46():86-99. PubMed ID: 10660791
[TBL] [Abstract][Full Text] [Related]
14. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
Fraeyman J; Verbelen M; Hens N; Van Hal G; De Loof H; Beutels P
Appl Health Econ Health Policy; 2013 Oct; 11(5):543-52. PubMed ID: 24062144
[TBL] [Abstract][Full Text] [Related]
15. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
16. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
Cheng N; Banerjee T; Qian J; Hansen RA
J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
[TBL] [Abstract][Full Text] [Related]
17. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
Mendoza RL
J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
[TBL] [Abstract][Full Text] [Related]
18. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
19. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
20. [Prescription of generic drugs to privately insured persons].
Wild F
Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
